| 1 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 2 |
Montserrat-Capdevila J, Godoy P, Marsal JR, et al. Overview of the impact of depression and anxiety in chronic obstructive pulmonary disease[J]. Lung, 2017, 195(1): 77-85.
|
| 3 |
Jang SM, Kim KU. Depression is a major determinant of both disease-specific and generic health-related quality of life in people with severe COPD[J]. Chron Respir Dis, 2019, 16: 1479972318775422.
|
| 4 |
Yohannes AM, Junkes-Cunha M, Smith J, et al. Management of dyspnea and anxiety in chronic obstructive pulmonary disease: A critical review[J]. J Am Med Dir Assoc, 2017, 18(12): 1096.e1-1096.e17.
|
| 5 |
Willgoss TG, Goldbart J, Fatoye F, et al. The development and validation of the anxiety inventory for respiratory disease[J]. Chest, 2013, 144(5): 1587-1596.
|
| 6 |
Baker AM, Holbrook JT, Yohannes AM, et al. Test performance characteristics of the AIR, GAD-7 and HADS-anxiety screening questionnaires for anxiety in chronic obstructive pulmonary disease[J]. Ann Am Thorac Soc, 2018. doi: 10.1513/AnnalsATS.201708-631OC. |
| 7 |
Omachi TA, Katz PP, Yelin EH, et al. Depression and health-related quality of life in chronic obstructive pulmonary disease[J]. Am J Med, 2009, 122(8): 778.e9-15.
|
| 8 |
Hanania NA, Mullerova H, Locantore NW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort[J]. Am J Respir Crit Care Med, 2011, 183(5): 604-611.
|
| 9 |
Lou P, Zhu Y, Chen P, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study[J]. BMC Pulm Med, 2012, 12: 53.
|
| 10 |
von Siemens SM, Jorres RA, Behr J, et al. Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study[J]. Respir Res, 2019, 20(1): 30.
|
| 11 |
Phan T, Carter O, Adams C, et al. Discriminant validity of the Hospital anxiety and Depression scale, Beck depression inventory (Ⅱ) and Beck anxiety inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease[J]. Chron Respir Dis, 2016, 13(3): 220-228.
|
| 12 |
Fan VS, Ramsey SD, Giardino ND, et al. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease[J]. Arch Intern Med, 2007, 167(21): 2345-2353.
|
| 13 |
Bock K, Bendstrup E, Hilberg O, et al. Screening tools for evaluation of depression in Chronic Obstructive Pulmonary Disease (COPD). A systematic review[J]. Eur Clin Respir J, 2017, 4(1): 1332931.
|
| 14 |
Webb CA, Rosso IM, Rauch SL. Internet-based cognitive-behavioral therapy for depression: Current progress and future directions[J]. Harv Rev Psychiatry, 2017, 25(3): 114-122.
|
| 15 |
Wenzel A. Basic strategies of cognitive behavioral therapy[J]. Psychiatr Clin North Am, 2017, 40(4): 597-609.
|
| 16 |
Hynninen MJ, Bjerke N, Pallesen S, et al. A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD[J]. Respir Med, 2010, 104(7): 986-994.
|
| 17 |
Norweg A, Collins EG. Evidence for cognitive-behavioral strategies improving dyspnea and related distress in COPD[J]. Int J Chron Obstruct Pulmon Dis, 2013, 8: 439-451.
|
| 18 |
Livermore N, Dimitri A, Sharpe L, et al. Cognitive behaviour therapy reduces dyspnoea ratings in patients with chronic obstructive pulmonary disease (COPD)[J]. Respir Physiol Neurobiol, 2015, 216: 35-42.
|
| 19 |
Moayeri F, Dunt D, Hsueh YA, et al. Cost-utility analysis of telephone-based cognitive behavior therapy in chronic obstructive pulmonary disease (COPD) patients with anxiety and depression comorbidities: an application for willingness to accept concept[J]. Expert Rev Pharmacoecon Outcomes Res, 2019, 19(3): 331-340.
|
| 20 |
Borson S, McDonald GJ, Gayle T, et al. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease[J]. Psychosomatics, 1992, 33(2): 190-201.
|
| 21 |
Moisieieva NV, Burya LV, Kapustianskaya AA, et al. Comprehensive patterns of comorbidity: copd and depression. Aspects of treatment [J]. Wiad Lek, 2018, 71(3 pt 1): 588-591.
|
| 22 |
Usmani ZA, Carson-Chahhoud KV, Esterman AJ, et al. A randomized placebo-controlled trial of paroxetine for the management of anxiety in chronic obstructive pulmonary disease (PAC Study)[J]. J Multidiscip Healthc, 2018, 11: 287-293.
|
| 23 |
张志滨，赵延宇，李 论. 文拉法辛在慢性阻塞性肺疾病伴焦虑抑郁治疗中的临床应用[J]. 中国实用医药，2017, 12(27): 106-108.
|
| 24 |
Gordon CS, Waller JW, Cook RM, et al. Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD: A systematic review and Meta-analysis[J]. Chest, 2019, 156(1): 80-91.
|
| 25 |
Ranjita R, Badhai S, Hankey A, et al. A randomized controlled study on assessment of health status, depression, and anxiety in coal miners with chronic obstructive pulmonary disease following yoga training[J]. Int J Yoga, 2016, 9(2): 137-144.
|